Abstract: Our invention relates to novel enantiomer derivatives of 8-hydroxyquinoline derivatives with general formula (I) and (II) and the synthesis thereof and pharmaceutically acceptable salts and metal complexes thereof, and the medicinal and/or pharmaceutical compositions comprising these compounds. The essence of the subject matter of the invention relates to the fact that prior art discloses the biological effect and characteristics only of the racemic products, the novel enantiomer derivatives according to the invention appear in our application for the first. The subject matter of the invention furthermore relates to a novel, stereoselective synthesis for the preparation of the novel enantiomer derivatives according to the invention. The novel medicinal and/or pharmaceutical compositions comprising these enantiomers are suitable for the treatment of the named diseases, and the enanatiomers are used for manufacture of these compositions.
Type:
Grant
Filed:
March 9, 2016
Date of Patent:
May 14, 2019
Assignees:
AVIDIN Co. Ltd., SONEAS Research Co. Ltd., Synaging SAS
Inventors:
László Puskás, István Kanizsai, Thierry Pillot, Márió Gyuris, András Szabó, Ferenc Takács, László Hackler